Emerging Players in the Vietnam Conjunctivitis Market | Competitive Landscape 2026

Emerging Players in the Vietnam Conjunctivitis Market

The Vietnam conjunctivitis market is categorized by a strategic blend of established local players and renowned multinational pharmaceutical companies. Major players are strengthening their market share, through continuous product innovation, introduction of advanced drug delivery systems, and strategic outreach programs for creating awareness about ocular health. The key players of the market are DHG Pharma, Stellapharm, Alcon, Santen Pharmaceutical, Bausch + Lomb, Novartis, Théa Pharma, GSK, Zuellig Pharma and DKSH Vietnam.

Vietnam Conjunctivitis Market Overview

According to 6Wresearch, the Vietnam conjunctivitis market is expected to rise at a steady rate, owing to the increasing prevalence of ocular allergies and bacterial infections, and the rising demand for patient-centric and accessible healthcare solutions. The market is evolving further, as consumers now demand high efficacy, convenient formulations that give fast relief from redness, itching and inflammation. There are several types of conjunctivitis products, ranging from sterile eye drops, ointments and advanced anti-infective suspensions for clinical and self-care.

Competitive Landscape

The competitive landscape in the Vietnam conjunctivitis industry includes global players in ophthalmic products, and local players with extensive local knowledge of the regulatory and market environment. The large corporations are engaging in research and development, concentrating on non-preserved products and green production methods, in order to address the demands of the growing middle-class population.

Below is a list of leading players operating in the Vietnam Conjunctivitis Market:

1. DHG Pharma

A leading domestic manufacturer providing a robust portfolio of affordable and widely accessible anti-infective and anti-inflammatory eye solutions.

2. Stellapharm J.V. Co., Ltd.

Specializes in the production of high-quality, generic ophthalmic formulations that cater to the evolving needs of the Vietnamese healthcare sector.

3. Alcon Vietnam

Offers a comprehensive portfolio of advanced surgical and vision care solutions, including specialized treatments for severe ocular infections.

4. Santen Pharmaceutical Co., Ltd.

A specialized ophthalmology company focused on developing advanced anti-infective and anti-inflammatory eye drops to improve patient quality of life.

5. Bausch + Lomb

Provides a diverse array of therapeutic options specifically formulated for managing chronic eye redness and infectious conjunctivitis.

6. Novartis Vietnam

Supplies high-quality specialty medicines and innovative therapeutic treatments for complex inflammatory ocular conditions.

7. Théa Pharma

Globally renowned for preservative-free ocular surface disease treatments, providing specialized care for sensitive eyes.

8. GSK (GlaxoSmithKline) Vietnam

A global healthcare entity providing essential anti-infective medicines and supporting broad-scale public health initiatives across Vietnam.

9. Zuellig Pharma Vietnam

A leading healthcare service provider that plays a critical role in the cold-chain distribution and accessibility of vital ophthalmic medications.

10. DKSH Vietnam

A cornerstone of the Vietnamese pharmaceutical supply chain, ensuring the widespread availability of eye care treatments for hospitals and retail pharmacies.

Emerging Players in the Vietnam Conjunctivitis Market: FAQs